A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors
Abstract Background α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor is a primary mediator of fast glutamatergic excitatory signaling in the brain and has been implicated in diverse neuropsychiatric diseases. We recently developed a novel positron emission tomography (PET) ligand, 2...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-08-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-017-0313-0 |
id |
doaj-ccda0efb0af84ee5ab13c5318aab6d87 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Keisuke Takahata Yasuyuki Kimura Chie Seki Masaki Tokunaga Masanori Ichise Kazunori Kawamura Maiko Ono Soichiro Kitamura Manabu Kubota Sho Moriguchi Tatsuya Ishii Yuhei Takado Fumitoshi Niwa Hironobu Endo Tomohisa Nagashima Yoko Ikoma Ming-Rong Zhang Tetsuya Suhara Makoto Higuchi |
spellingShingle |
Keisuke Takahata Yasuyuki Kimura Chie Seki Masaki Tokunaga Masanori Ichise Kazunori Kawamura Maiko Ono Soichiro Kitamura Manabu Kubota Sho Moriguchi Tatsuya Ishii Yuhei Takado Fumitoshi Niwa Hironobu Endo Tomohisa Nagashima Yoko Ikoma Ming-Rong Zhang Tetsuya Suhara Makoto Higuchi A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors EJNMMI Research PET Perampanel AMPA [11C]HMS011 Interspecies differences |
author_facet |
Keisuke Takahata Yasuyuki Kimura Chie Seki Masaki Tokunaga Masanori Ichise Kazunori Kawamura Maiko Ono Soichiro Kitamura Manabu Kubota Sho Moriguchi Tatsuya Ishii Yuhei Takado Fumitoshi Niwa Hironobu Endo Tomohisa Nagashima Yoko Ikoma Ming-Rong Zhang Tetsuya Suhara Makoto Higuchi |
author_sort |
Keisuke Takahata |
title |
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors |
title_short |
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors |
title_full |
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors |
title_fullStr |
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors |
title_full_unstemmed |
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors |
title_sort |
human pet study of [11c]hms011, a potential radioligand for ampa receptors |
publisher |
SpringerOpen |
series |
EJNMMI Research |
issn |
2191-219X |
publishDate |
2017-08-01 |
description |
Abstract Background α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor is a primary mediator of fast glutamatergic excitatory signaling in the brain and has been implicated in diverse neuropsychiatric diseases. We recently developed a novel positron emission tomography (PET) ligand, 2-(1-(3-([11C]methylamino)phenyl)-2-oxo-5-(pyrimidin-2-yl)-1,2-dihydropyridin-3-yl) benzonitrile ([11C]HMS011). This compound is a radiolabelled derivative of perampanel, an antiepileptic drug acting on AMPA receptors, and was demonstrated to have promising in vivo properties in the rat and monkey brains. In the current study, we performed a human PET study using [11C]HMS011 to evaluate its safety and kinetics. Four healthy male subjects underwent a 120-min PET scan after injection of [11C]HMS011. Arterial blood sampling and metabolite analysis were performed to obtain parent input functions for three of the subjects using high-performance liquid chromatography. Regional distribution volumes (V Ts) were calculated based on kinetic models with and without considering radiometabolite in the brain. The binding was also quantified using a reference tissue model with white matter as reference. Results Brain uptake of [11C]HMS011 was observed quickly after the injection, followed by a rapid clearance. Three hydrophilic and one lipophilic radiometabolites appeared in the plasma, with notable individual variability. The kinetics in the brain with apparent radioactivity retention suggested that the lipophilic radiometabolite could enter the brain. A dual-input graphical model, an analytical model designed in consideration of a radiometabolite entering the brain, well described the kinetics of [11C]HMS011. A reference tissue model showed small radioligand binding potential (BP*ND) values in the cortical regions (BP*ND = 0–0.15). These data suggested specific binding component of [11C]HMS011 in the brain. Conclusions Kinetic analyses support some specific binding of [11C]HMS011 in the human cortex. However, this ligand may not be suitable for practical AMPA receptor PET imaging due to the small dynamic range and metabolite in the brain. |
topic |
PET Perampanel AMPA [11C]HMS011 Interspecies differences |
url |
http://link.springer.com/article/10.1186/s13550-017-0313-0 |
work_keys_str_mv |
AT keisuketakahata ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT yasuyukikimura ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT chieseki ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT masakitokunaga ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT masanoriichise ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT kazunorikawamura ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT maikoono ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT soichirokitamura ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT manabukubota ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT shomoriguchi ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT tatsuyaishii ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT yuheitakado ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT fumitoshiniwa ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT hironobuendo ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT tomohisanagashima ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT yokoikoma ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT mingrongzhang ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT tetsuyasuhara ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT makotohiguchi ahumanpetstudyof11chms011apotentialradioligandforampareceptors AT keisuketakahata humanpetstudyof11chms011apotentialradioligandforampareceptors AT yasuyukikimura humanpetstudyof11chms011apotentialradioligandforampareceptors AT chieseki humanpetstudyof11chms011apotentialradioligandforampareceptors AT masakitokunaga humanpetstudyof11chms011apotentialradioligandforampareceptors AT masanoriichise humanpetstudyof11chms011apotentialradioligandforampareceptors AT kazunorikawamura humanpetstudyof11chms011apotentialradioligandforampareceptors AT maikoono humanpetstudyof11chms011apotentialradioligandforampareceptors AT soichirokitamura humanpetstudyof11chms011apotentialradioligandforampareceptors AT manabukubota humanpetstudyof11chms011apotentialradioligandforampareceptors AT shomoriguchi humanpetstudyof11chms011apotentialradioligandforampareceptors AT tatsuyaishii humanpetstudyof11chms011apotentialradioligandforampareceptors AT yuheitakado humanpetstudyof11chms011apotentialradioligandforampareceptors AT fumitoshiniwa humanpetstudyof11chms011apotentialradioligandforampareceptors AT hironobuendo humanpetstudyof11chms011apotentialradioligandforampareceptors AT tomohisanagashima humanpetstudyof11chms011apotentialradioligandforampareceptors AT yokoikoma humanpetstudyof11chms011apotentialradioligandforampareceptors AT mingrongzhang humanpetstudyof11chms011apotentialradioligandforampareceptors AT tetsuyasuhara humanpetstudyof11chms011apotentialradioligandforampareceptors AT makotohiguchi humanpetstudyof11chms011apotentialradioligandforampareceptors |
_version_ |
1716766328820334592 |
spelling |
doaj-ccda0efb0af84ee5ab13c5318aab6d872020-11-24T21:06:13ZengSpringerOpenEJNMMI Research2191-219X2017-08-017111010.1186/s13550-017-0313-0A human PET study of [11C]HMS011, a potential radioligand for AMPA receptorsKeisuke Takahata0Yasuyuki Kimura1Chie Seki2Masaki Tokunaga3Masanori Ichise4Kazunori Kawamura5Maiko Ono6Soichiro Kitamura7Manabu Kubota8Sho Moriguchi9Tatsuya Ishii10Yuhei Takado11Fumitoshi Niwa12Hironobu Endo13Tomohisa Nagashima14Yoko Ikoma15Ming-Rong Zhang16Tetsuya Suhara17Makoto Higuchi18Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Molecular Imaging and Theranostics, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyDepartment of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and TechnologyAbstract Background α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor is a primary mediator of fast glutamatergic excitatory signaling in the brain and has been implicated in diverse neuropsychiatric diseases. We recently developed a novel positron emission tomography (PET) ligand, 2-(1-(3-([11C]methylamino)phenyl)-2-oxo-5-(pyrimidin-2-yl)-1,2-dihydropyridin-3-yl) benzonitrile ([11C]HMS011). This compound is a radiolabelled derivative of perampanel, an antiepileptic drug acting on AMPA receptors, and was demonstrated to have promising in vivo properties in the rat and monkey brains. In the current study, we performed a human PET study using [11C]HMS011 to evaluate its safety and kinetics. Four healthy male subjects underwent a 120-min PET scan after injection of [11C]HMS011. Arterial blood sampling and metabolite analysis were performed to obtain parent input functions for three of the subjects using high-performance liquid chromatography. Regional distribution volumes (V Ts) were calculated based on kinetic models with and without considering radiometabolite in the brain. The binding was also quantified using a reference tissue model with white matter as reference. Results Brain uptake of [11C]HMS011 was observed quickly after the injection, followed by a rapid clearance. Three hydrophilic and one lipophilic radiometabolites appeared in the plasma, with notable individual variability. The kinetics in the brain with apparent radioactivity retention suggested that the lipophilic radiometabolite could enter the brain. A dual-input graphical model, an analytical model designed in consideration of a radiometabolite entering the brain, well described the kinetics of [11C]HMS011. A reference tissue model showed small radioligand binding potential (BP*ND) values in the cortical regions (BP*ND = 0–0.15). These data suggested specific binding component of [11C]HMS011 in the brain. Conclusions Kinetic analyses support some specific binding of [11C]HMS011 in the human cortex. However, this ligand may not be suitable for practical AMPA receptor PET imaging due to the small dynamic range and metabolite in the brain.http://link.springer.com/article/10.1186/s13550-017-0313-0PETPerampanelAMPA[11C]HMS011Interspecies differences |